Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07322367 · ClinicalTrials.gov registry record · NA
A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
A NA study, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 27,000
- Enrollment target
NCT07322367 is a NA study that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 27,000 participants.
The verdict
NCT07322367, a NA study, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 27,000 participants
- Enrollment target
Study Summary
To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.
Interventions
- OTHER Usual Care
- OTHER Portal Message with Reminder Text Messages
- OTHER Text Message with Reminder Text Messages
- OTHER Portal message only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,000 participants |
| Start Date | 2026-03-25 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07322367
The ClinicalTrials.gov registry entry for NCT07322367 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 27,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT07322367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07322367 about?
NCT07322367 is a clinical study titled "A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients". To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fu...
What is the current status of trial NCT07322367?
This trial is currently recruiting. It is a NA study. The enrollment target is 27,000 participants. The study started on 2026-03-25. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07322367?
The interventions under investigation include: Usual Care (OTHER), Portal Message with Reminder Text Messages (OTHER), Text Message with Reminder Text Messages (OTHER), Portal message only (OTHER).
Who is sponsoring clinical trial NCT07322367?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.